The $50,000 prize will be shared between John Curtin Distinguished Professor Sharon Parker from Curtin University, and Professor Markus Schlaich from The University of Western Australia, Royal Perth Hospital and RPH Research Foundation.

Professor Schlaich's translational clinical research has resulted in recent regulatory approval of several novel blood pressure lowering therapies, including a new drug class and a revolutionary interventional approach to treat hypertension.

As Chair of Hypertension Australia and Co-Chair of the recently established National Hypertension Taskforce, Professor Schlaich leads the nation in controlling the leading global risk factor for death. With more than 500 publications and 20 national/international awards, his translational clinical research has resulted in recent regulatory approval of several novel blood pressure lowering therapies including a new drug class and a revolutionary interventional approach to treat hypertension.

Applications came from across all fields of science, including natural, medical, applied and technological science, engineering and mathematics.

Winners were selected by panels of expert judges who oversaw the assessment process.

Congratulations to Professor Markus Schlaich and all the Premier’s Science Awards winners.